Literature DB >> 25527322

Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential.

Kaitlin C Murphy1, Marissa L Hughbanks, Bernard Y K Binder, Caroline B Vissers, J Kent Leach.   

Abstract

Mesenchymal stem/stromal cells (MSCs) are under examination for use in cell therapies to repair bone defects resulting from trauma or disease. MSCs secrete proangiogenic cues and can be induced to differentiate into bone-forming osteoblasts, yet there is limited evidence that these events can be achieved in parallel. Manipulation of the cell delivery vehicle properties represents a candidate approach for directing MSC function in bone healing. We hypothesized that the biophysical properties of a fibrin gel could simultaneously regulate the proangiogenic and osteogenic potential of entrapped MSCs. Fibrin gels were formed by supplementation with NaCl (1.2, 2.3, and 3.9% w/v) to modulate gel biophysical properties without altering protein concentrations. MSCs entrapped in 1.2% w/v NaCl gels were the most proangiogenic in vitro, yet cells in 3.9% w/v gels exhibited the greatest osteogenic response. Compared to the other groups, MSCs entrapped in 2.3% w/v gels provided the best balance between proangiogenic potential, osteogenic potential, and gel contractility. The contribution of MSCs to bone repair was then examined when deployed in 2.3% w/v NaCl gels and implanted into an irradiated orthotopic bone defect. Compared to acellular gels after 3 weeks of implantation, defects treated with MSC-loaded fibrin gels exhibited significant increases in vessel density, early osteogenesis, superior morphology, and increased cellularity of repair tissue. Defects treated with MSC-loaded gels exhibited increased bone formation after 12 weeks compared to blank gels. These results confirm that fibrin gel properties can be modulated to simultaneously promote both the proangiogenic and osteogenic potential of MSCs, and fibrin gels modified by supplementation with NaCl are promising carriers for MSCs to stimulate bone repair in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527322      PMCID: PMC4475511          DOI: 10.1007/s10439-014-1227-x

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  50 in total

Review 1.  Fibrinopeptides and fibrin gel structure.

Authors:  Birger Blombäck; Niklas Bark
Journal:  Biophys Chem       Date:  2004-12-20       Impact factor: 2.352

Review 2.  The biology of bone grafting.

Authors:  Safdar N Khan; Frank P Cammisa; Harvinder S Sandhu; Ashish D Diwan; Federico P Girardi; Joseph M Lane
Journal:  J Am Acad Orthop Surg       Date:  2005 Jan-Feb       Impact factor: 3.020

3.  Matrix elasticity directs stem cell lineage specification.

Authors:  Adam J Engler; Shamik Sen; H Lee Sweeney; Dennis E Discher
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

4.  New method to prepare autologous fibrin glue on demand.

Authors:  Steven M Alston; Kenneth A Solen; Adam H Broderick; Sivaprasad Sukavaneshvar; S Fazal Mohammad
Journal:  Transl Res       Date:  2007-04       Impact factor: 7.012

5.  Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation.

Authors:  Cyrus M Ghajar; Katherine S Blevins; Christopher C W Hughes; Steven C George; Andrew J Putnam
Journal:  Tissue Eng       Date:  2006-10

6.  VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects.

Authors:  Darnell Kaigler; Zhuo Wang; Kim Horger; David J Mooney; Paul H Krebsbach
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

7.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

Authors:  Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

8.  Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro.

Authors:  Isabelle Catelas; Nadjah Sese; Benjamin M Wu; James C Y Dunn; Sam Helgerson; Bill Tawil
Journal:  Tissue Eng       Date:  2006-08

9.  Human mesenchymal stem cells as a stable source of VEGF-producing cells.

Authors:  Harumi Kagiwada; Tetsuya Yashiki; Akira Ohshima; Mika Tadokoro; Noritoshi Nagaya; Hajime Ohgushi
Journal:  J Tissue Eng Regen Med       Date:  2008-06       Impact factor: 3.963

Review 10.  Osteogenesis and angiogenesis: the potential for engineering bone.

Authors:  J M Kanczler; R O C Oreffo
Journal:  Eur Cell Mater       Date:  2008-05-02       Impact factor: 3.942

View more
  13 in total

1.  Bone Morphogenetic Protein-2 Promotes Human Mesenchymal Stem Cell Survival and Resultant Bone Formation When Entrapped in Photocrosslinked Alginate Hydrogels.

Authors:  Steve S Ho; Nina L Vollmer; Motasem I Refaat; Oju Jeon; Eben Alsberg; Mark A Lee; J Kent Leach
Journal:  Adv Healthc Mater       Date:  2016-09-01       Impact factor: 9.933

2.  Neurogenic potential of engineered mesenchymal stem cells overexpressing VEGF.

Authors:  Alan J Man; Gregory Kujawski; Travis S Burns; Elaine N Miller; Fernando A Fierro; J Kent Leach; Peter Bannerman
Journal:  Cell Mol Bioeng       Date:  2016-01-13       Impact factor: 2.321

3.  Injectable mineralized microsphere-loaded composite hydrogels for bone repair in a sheep bone defect model.

Authors:  Ganesh C Ingavle; Marissa Gionet-Gonzales; Charlotte E Vorwald; Laurie K Bohannon; Kaitlin Clark; Larry D Galuppo; J Kent Leach
Journal:  Biomaterials       Date:  2019-01-10       Impact factor: 12.479

4.  Multi-peptide presentation and hydrogel mechanics jointly enhance therapeutic duo-potential of entrapped stromal cells.

Authors:  Ben P Hung; Tomas Gonzalez-Fernandez; Jenny B Lin; Takeyah Campbell; Yu Bin Lee; Alyssa Panitch; Eben Alsberg; J Kent Leach
Journal:  Biomaterials       Date:  2020-03-20       Impact factor: 12.479

5.  Hydrogel biophysical properties instruct coculture-mediated osteogenic potential.

Authors:  Kaitlin C Murphy; Roberta S Stilhano; Debika Mitra; Dejie Zhou; Samir Batarni; Eduardo A Silva; J Kent Leach
Journal:  FASEB J       Date:  2015-10-06       Impact factor: 5.191

6.  Engineering fibrin hydrogels to promote the wound healing potential of mesenchymal stem cell spheroids.

Authors:  Kaitlin C Murphy; Jacklyn Whitehead; Dejie Zhou; Steve S Ho; J Kent Leach
Journal:  Acta Biomater       Date:  2017-10-05       Impact factor: 8.947

7.  Assessment of stem cell viability in the initial healing period in rabbits with a cranial bone defect according to the type and form of scaffold.

Authors:  Seung-Hwan Kang; Jun-Beom Park; InSoo Kim; Won Lee; Heesung Kim
Journal:  J Periodontal Implant Sci       Date:  2019-08-09       Impact factor: 2.614

8.  Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling.

Authors:  Kaitlin C Murphy; Allison I Hoch; Jenna N Harvestine; Dejie Zhou; J Kent Leach
Journal:  Stem Cells Transl Med       Date:  2016-06-30       Impact factor: 6.940

Review 9.  A review of fibrin and fibrin composites for bone tissue engineering.

Authors:  Alireza Noori; Seyed Jamal Ashrafi; Roza Vaez-Ghaemi; Ashraf Hatamian-Zaremi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2017-07-12

10.  Osteogenic preconditioning in perfusion bioreactors improves vascularization and bone formation by human bone marrow aspirates.

Authors:  J N Harvestine; T Gonzalez-Fernandez; A Sebastian; N R Hum; D C Genetos; G G Loots; J K Leach
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.